failure to disclose COI – Page 2

Prominent Chinese scientist failed to disclose company ties in COVID-19 clinical trial paper

Nanshan Zhong, by 东方(美國之音記者) via Wikimedia

One of China’s leading scientists in the fight against COVID-19 failed to disclose ties to a pharmaceutical company in a paper stemming from a clinical trial, Retraction Watch has learned. A co-author on the paper is married to the daughter of that pharmaceutical company’s founder, who herself sits on the firm’s board of directors.

Nanshan Zhong first rose to prominence during the 2003 SARS outbreak for developing “a controversial steroid treatment that cured many SARS patients but left some with debilitating bone issues,” according to NPR. In 2020, TIME named him to the magazine’s list of the world’s 100 most influential people. He was appointed to lead China’s National Health Commission investigation into COVID-19 early last year, and in February 2020 Harvard announced that Zhong would share in a $115 million effort with university scientists to develop therapies for COVID-19.

Last May, Zhong published results from a clinical trial that tested whether a traditional Chinese medicine could be used to treat COVID-19 patients. That paper, titled “Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial,” was published in Phytomedicine. It has been cited 67 times, according to Clarivate Analytics’ Web of Science, and has two corresponding authors: Zhong, of the Guangzhou Institute of Respiratory Health, and Zhen-hua Jia of Hebei Yiling Hospital, in China.

Eleven papers corrected after nutrition prof fails to disclose patent, company ties

Eight journals have corrected a total of eleven papers after one of the authors failed to list potential financial conflicts of interest. Two additional journals have also told Retraction Watch that they plan to issue corrections, which will bring the total to 13 or more.

Stuart Phillips is a professor and director of the Centre for Nutrition, Exercise, and Health Research at McMaster University in Hamilton, Ontario. The corrected studies — which now reflect Phillips’ links to companies or patents — are all related to his research on nutritional supplements and exercise.

One journal, Medicine & Science in Sports & Exercise, issued a single correction for four studies authored by Phillips:

PLOS ONE issues expression of concern for study of dog food and heart problems for failure to disclose conflicts of interest, other issues

via Southern California Golden Retriever Rescue

A group of veterinary researchers at the University of California, Davis, has received an expression of concern for their May 2020 study on heart disease in dogs, for failing to adequately disclose conflicts of interest and for other aspects of the article.

The paper, “Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study,” appeared in PLOS ONE. The authors, from the lab of Joshua A. Stern, looked at the effects on the animals of “non-traditional” diets — those high in legumes but low in grains, which contain taurine, a key amino acid. Golden retrievers are known to be particularly vulnerable to cardiac problems associated with a lack of taurine. The FDA has been investigating the connection.

According to the authors:

Duke engineering prof corrects seven papers for failures to disclose startup he co-founded

A chemistry journal has issued corrections for seven papers after learning that one of the authors failed to list his ownership of a company with a stake in the research.

The articles, which appeared in Lab on a Chip — a journal “at the interface between physical technological advancements and high impact applications” from the Royal Society of Chemistry — came from the lab of Tony Jun Huang, of Duke University in Durham, N.C. Huang, who holds the William Bevan Distinguished Professor of Mechanical Engineering and Materials Science at Duke, is a prominent figure in the field. According to his bio:

Publisher slaps expressions of concern on 20 papers by nutrition supplement-selling doctor

More than two years after being made aware of undisclosed conflicts of interest by a Minnesota physician who ran afoul of the U.S. FDA for health claims about supplements sold by his company, a publisher has added expressions of concern on 20 of the doctor’s papers.

As we reported in August 2019, on Feb. 23, 2018, Stephen Barrett — a U.S. physician and founder of Quackwatch — sent Dove Press a message about the 20 papers by Marty Hinz:

Conflicts of disinterest: Why does it take a publisher 18 months, and counting, to correct papers?

On February 23, 2018, Stephen Barrett — a physician in the United States perhaps best known for his work at Quackwatch — sent Dove Press this message:

I believe you have published 20 articles in 6 of your journals in which the lead author did not make a full conflict-of-interest disclosure. Please email me directly with the name and email address of an individual to whom I should report.

The lead author in question was Marty Hinz. As Barrett writes in a summary of the case:

In wake of media scrutiny, Sloan Kettering author adds financial disclosures

A month after a journalism investigation that led to resignations and turmoil at Memorial Sloan Kettering Cancer Center in New York, researchers including a Sloan Kettering scientist have quietly corrected at least two papers to add disclosures of financial conflicts of interest.

The two corrections, in Chemistry of Materials, are dated October 8, 2018 and read: Continue reading In wake of media scrutiny, Sloan Kettering author adds financial disclosures

Journal flags papers, saying authors didn’t adequately disclose ties to Monsanto

A toxicology journal has issued an expression of concern for a group of papers about the controversial herbicide glyphosate after concluding that some of the authors didn’t adequately disclose their ties to the maker of the product.

At issue are five articles that appeared in a 2016 supplement to Critical Reviews in Toxicology, a Taylor & Francis title, about the chemical, the active ingredient in Monsanto’s blockbuster weed-killer Roundup. Although the authors of the articles don’t overlap perfectly, Keith Solomon, of the University of Guelph, in Canada, appears on three of the articles; Gary Williams, of New York Medical College, appears on three as well.

Williams was caught up in a ghost-writing scandal after court documents revealed that he had put his name on a published paper written by Monsanto employees. Solomon served on a panel funded by Monsanto that undercut the conclusions of a report from the World Health Organization that glyphosate is probably cancerous to people.

According to the expression of concern, which was first reported by Bloomberg today: Continue reading Journal flags papers, saying authors didn’t adequately disclose ties to Monsanto

Caught Our Notice: Climate change leads to more…neurosurgery for polar bears?

Title: Internet Blogs, Polar Bears, and Climate-Change Denial by Proxy

What Caught Our Attention: There’s a lot going on here, so bear with us. (Ba-dum-bum.)

First, there was the paper itself, co-authored by, among others, Michael Mann and Stephan Lewandowsky. Both names may be familiar to Retraction Watch readers. Mann is a prominent climate scientist who has sued the National Review for defamation. A study by Lewandowsky and colleagues of “the role of conspiracist ideation in climate denial” was the subject of several Retraction Watch posts when it was retracted and then republished in a different form. And the conclusion of the new paper, in Bioscience, seemed likely to draw the ire of many who objected to the earlier work: Continue reading Caught Our Notice: Climate change leads to more…neurosurgery for polar bears?

Journal retracts letter for missing disclosure author says he tried to submit

An emergency medicine journal has retracted a letter to the editor, saying it didn’t include the author’s relevant commercial interest—which the author says he tried to disclose when he submitted the paper.

The author, Guy Weinberg, told Retraction Watch he had noted his conflict of interest when he submitted the letter last March, but said he did not use the journal’s disclosure form. He added that his primary concern is that the editors didn’t reach out to him to discuss the issue prior to retracting the letter.

Here’s the retraction notice for “Assessing Efficacy of Lipid in Unstable, non-LAST Overdose Patients,” published on Sept. 18 in the Canadian Journal of Emergency Medicine: Continue reading Journal retracts letter for missing disclosure author says he tried to submit

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: